HCMSG - Hepatitis C Mentor & Support Group, Inc.
Search
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
  • Resources
    • COVID-19
    • Harm Reduction
    • Hep C Risks
    • Hep C Facts & Stats
    • Medications and Treatments >
      • Patient Assistance Programs
    • Reading
    • Links
  • Programs/Training
    • The Circle Model >
      • THE CIRCLE Registration
      • Group and Facilitator Guide
      • Circle Sites
    • Hepatitis C Online Training
    • The Hepatitis C Education and Support Group Assistance Program
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
  • Contact Us

INSURANCE COMPANY'S ACTION COULD MEAN BIG THINGS FOR HEPATITIS C SUFFERERS

1/13/2017

0 Comments

 
JoAnn Seltzer Jan. 11, 2017, 12:39pm
SAN FRANCISCO — More patients will have access to a life-saving medicine after a decision was made recently by a large insurer.
According to Modern Healthcare, Blue Shield Life and Health and Blue Shield of California was facing a class-action suit in Northern California after it initially denied a costly Hepatitis C medicine to some patients. The lawsuit was dismissed by a federal judge last week after Blue Shield decided to expand coverage on the drug Harvoni. Previously, the company only covered the medicine for the sickest patients.


Ryan Clary, executive director of The National Viral Hepatitis Roundtable, told The Northern California Record he believes everyone who has Hepatitis C who wants to be cured and has insurance and a provider willing to treat them should have access to the medicine.
“Most people would like to be cured of an infection, that's a chronic, often life-threatening disease, before severe health complications arise,” he said. “Being able to get rid of the anxiety of having a very severe virus that attacks the liver is, for us, reason enough.”
Hepatitis C can lead to a lot of complications from fatigue and muscle pain to liver disease. It's also the leading cause of liver cancer, Clary said. The effects of the disease vary from person to person.
In addition to healing the sick, providing access to this class of medicine can prevent the spread of it, he said.
Clary added that a person living with Hepatitis C may not be suffering from liver disease, but may continue engaging in risky behavior putting other people at risk, he said. If the person is cured they will no longer be infecting others.
Hepatitis C currently kills more people than any other infectious disease in the United States including HIV, Clary said.
“We have the opportunity to actually eliminate Hepatitis C in the United States. The tools are out there,” he said. “It's a serious public-health threat.”
Prior to Harvoni and other drugs in its class, patients had to use a drug that needed to be injected by the patient for 48 weeks. Severe side effects, similar to chemotherapy, prevented many from even finishing the treatment, he said.
Reservations about making it available to all insured patients is probably a combination of two factors, Clary said. The course of treatment needed can cost $100,000. Plus, there is a stigma attached to Hepatitis C in some cases.
Clary said one way it can be spread is by the sharing of needles and the current opioid epidemic in California and the nation has helped to spread the disease.
It's unfortunate that patients have to sue to get access to treatment, Clary said, but he is hopeful that cases like this will mean insurance companies will be less inclined to put such strict restrictions on life-saving medicine in the future.
“I can't think of any other health condition where you would tell somebody we're going to wait until you get really sick before we treat you or in this case cure you. It just doesn't make any sense,” he said.

​http://norcalrecord.com/stories/511069325-insurance-company-s-action-could-mean-big-things-for-hepatitis-c-sufferers

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy